Connect with us

Headlines

Hilco Makes an Acquisition

The deal was completed Nov. 30.

mm

Published

on

PLAINVILLE, MA — Hilco Vision has acquired Tucson, AZ-based ophthalmic supplies company Eye Care and Cure.

Terms of the deal, which was completed Nov. 30, were not disclosed.

Ross Brownlee, CEO of Hilco Vision, said, “Eye Care and Cure has built a superb reputation addressing the pharmaceutical and diagnostic needs of its customers over many years through its subject matter expertise, breadth of line, quality of service and desire to simplify the buying experience for its customers – common qualities to the aspirations of the Wilson Ophthalmic division and Hilco Vision as a group.

“I am confident the value proposition we have for our combined customer base is really enhanced by this acquisition and look forward to building further on this new platform.”

For now, the businesses will operate independently, according to a press release. Eye Care and Cure will begin carrying some key items from the Hilco Vision portfolio, including Hilco’s line of professional optical tools and lens cleaners. The Hilco Vision portfolio will include an expanded pharmaceutical selection and unique ECC products.

“We felt that Eye Care and Cure would be even better placed to continue to expand our offering to our customers as part of a bigger group and Hilco Vision was the obvious choice from the standpoint of capabilities and aligned purpose and values,” said Dr. Johan Van Dalen, CEO of Eye Care and Cure, who will support the transition to new ownership and continue to consult on product innovation.

Advertisement

Together Hilco Vision and Eye Care and Cure offer a national distribution network for eyecare professionals with over 30,000 products in stock, including pharmaceuticals, diagnostics, vision care and optical products. John Lakey, chief operating officer of Eye Care and Cure, will join Hilco Vision as head of the ophthalmic supplies division.

Advertisement

SPONSORED VIDEO

SPONSORED BY REICHERT

See How the Reichert Phoroptor® VRx Transformed this Eye Care Practice

When Rochester, NY-based Eyesite designed its beautiful new facility, optometrists Benjamin Peters and Justin Verone chose the Reichert® Phoroptor® VRx. With its state-of-the art design and performance, the designed and assembled in the U.S.A. Phoroptor VRx has saved both time and money, say the owners. See how technology and design work together to provide Eyesite’s patients with an optimal eye care experience. This is the first in a video series created by Reichert to share stories from professionals who are passionate about eye care, their patients, technology and practice management.For more information about the Reichert® Phoroptor® VRx, click here.

Promoted Headlines

Headlines

Pharma Company with Eyecare Focus Names CEO

He previously served as interim chief.

mm

Published

on

EMERYVILLE, CA — NovaBay Pharmaceuticals Inc., a biopharmaceutical company focusing on commercializing Avenova for the domestic eye care market, announces the appointments of Justin Hall as president and CEO and Jason Raleigh as chief financial officer.

Hall has served as interim president and CEO, and Raleigh as interim CFO, since March 2019.

“Justin and Jason have proven their leadership abilities by successfully implementing the shift in our U.S. commercial strategy we announced in March and executing the recent launch of our U.S. direct-to-consumer sales of Avenova on Amazon.com,” said Paul E. Freiman, chairman of NovaBay.

“This is a very exciting time at NovaBay as we launch Avenova Direct, making our leading lid and lash spray directly accessible to consumers without a prescription and at affordable pricing,” Hall said. “My close working relationships with our Board, principal investors, and sales force are key to quickly adjusting our strategy to rapidly address opportunities in the marketplace. We are on the move and we have momentum.”

Advertisement

Raleigh said: “I’m honored to be selected as CFO and appreciate the Board’s trust in my abilities. I look forward to continuing to work with Justin and the NovaBay team toward the continued successful commercialization of Avenova.”

Hall has served with NovaBay for six years in a variety of roles, including as corporate counsel, and has been actively involved in a number of operating functions, including the sales organization and manufacturing. Raleigh has been with NovaBay for more than three years and has nearly 20 years of financial experience.

Continue Reading

Headlines

AOA: Amazon Has Dropped Noncompliant Contact Lens Sellers

AOA plans to ‘continue to monitor the site and report retailers.’

mm

Published

on

The American Optometric Association reports that Amazon’s marketplace no longer displays noncompliant, decorative contact lens vendors following complaints from the AOA.

The AOA explains that it had alerted the e-commerce retailer to potential violations of federal law and its own medical device policy.

In a Feb. 27 letter to Amazon, the AOA emphasized that contact lenses — whether corrective or plano — are U.S. Food and Drug Administration-regulated medical devices that not only require a prescription from a licensed practitioner for purchase, but also fall under Amazon’s own policy for “Medical Devices and Accessories.” That policy mandates how sellers must abide by all federal, state and local laws, which in this case, the AOA noted, includes patient protection provisions of the Fairness to Contact Lens Consumer Act (FCLCA).

Per federal law, vendors “may sell contact lenses only in accordance with a contact lens prescription for the patient that is (1) presented to the seller by the patient or prescriber directly or by facsimile; or (2) verified by direct communication.”

AOA’s letter noted: “The contact lenses available for sale on Amazon are sold entirely without a prescription, which we believe is an FCLCA violation.” Furthermore, “in addition to sales via (Amazon’s) platform raising legal questions related to the FCLCA, the guidance provided by sellers regarding these FDA-regulated medical devices is very concerning.”

The AOA’s letter document instructions from vendors such as “… gently press the contact lens opposite clockwise or counterclockwise turn 30 times [sic], and put in a box for a new care solution … if you do not use for a long time, please put in the box, soak with care solution [sic], replace the care solution every three days.”

Such guidance is “wholly inappropriate and dangerous,” the AOA states in a post on its website. It notes that proper physician oversight is necessary for medical devices that require a physician’s prescription.

According to AOA:

In response, Amazon thanked AOA for its diligence and reiterated its own medical devices policy while stating the company will take appropriate action when products are reported for legal non-compliance. As of June 4, those violating posts that AOA first identified and reported have been removed. The AOA will continue to monitor the site and report retailers.

Continue Reading

Headlines

Ophthalmologists Hope to Undo State Law That Allows ODs to Perform Eye Surgery

They’re attempting a ballot referendum.

mm

Published

on

A movement is afoot in Arkansas to undo recently passed state legislation that allows optometrists to perform certain surgeries.

It’s being led by Safe Surgery Arkansas, a group of medical doctors, Talk Business & Politics reports. They hope to use a ballot referendum to accomplish their goal.

R. Scott Lowery, president of the Arkansas Ophthalmological Society, was quoted saying: “Every day the people of Arkansas rely on medical doctors who have the experience and training to perform medical procedures to ensure that they are getting world class healthcare in Arkansas. We are confident that when the people are heard on this issue, they will not allow individuals without medical degrees and without surgical residencies to jeopardize the precious eyesight of Arkansans.”

The legislation was signed into law in March. The procedures that it allows optometrists to perform include selective laser trabeculoplasty and Nd:YAG laser procedures, along with injections (excluding intravenous and intraocular), removal of lid lesions and chalazion incision and curettage.

Advertisement

The bill called on the Arkansas Board of Optometry to establish credentialing requirements for optometrists to perform these laser procedures, as well as require those doctors to report the outcomes of their procedures to the board.

Vicki Farmer, executive director of the Arkansas Optometry Association, was quoted noting that Arkansas legislators “overwhelmingly approved this measure during the recent session, after listening to hours of testimony and debate, and learning optometrists in other states, like Oklahoma, have been safely performing these procedures for more than 20 years.”

Read more at Talk Business & Politics

Continue Reading

Advertisement

Advertisement

Advertisement

Subscribe


BULLETINS

Get the most important news and business ideas for eyecare professionals every weekday from INVISION.

Facebook

Most Popular